|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.70 EUR | +1.92% |
|
+0.12% | +36.23% |
| Aug. 04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| Aug. 03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
| Market Cap | 13.27B 15.29B 12.43B 11.37B 21.43B 1,455B 21.75B 145B 57.06B 729B 57.41B 56.16B 2,424B | P/E 2026 * |
13.4x | P/E 2027 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 11.89B 13.7B 11.13B 10.18B 19.19B 1,303B 19.48B 130B 51.1B 653B 51.42B 50.29B 2,170B | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.4x |
| Free-Float |
40.65% | Yield 2026 * |
0.95% | Yield 2027 * | 0.95% |
Last Transcript: Ipsen
| 1 day | +1.92% | ||
| 1 week | +0.12% | ||
| Current month | -3.29% | ||
| 1 month | -4.97% | ||
| 3 months | -4.38% | ||
| 6 months | +19.42% | ||
| Current year | +36.23% |
| 1 week | 153.1 |  | 171.8 |
| 1 month | 153.1 | | 171.8 |
| Current year | 116 | | 176.6 |
| 1 year | 104.7 | | 176.6 |
| 3 years | 88.05 | | 176.6 |
| 5 years | 77.28 | | 176.6 |
| 10 years | 35.52 | | 176.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 2020-06-30 |
| Chief Executive Officer | 57 | 2019-12-31 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 2005-08-29 |
| Chairman | 68 | 2010-11-21 | |
Carol Xueref
BRD | Director/Board Member | 69 | 2012-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.92% | +0.12% | - | - | 15.12B | |
| +1.89% | -1.49% | +55.62% | +165.18% | 1,043B | |
| -0.24% | -3.22% | +50.51% | +52.02% | 621B | |
| -0.95% | -7.38% | +22.83% | +65.08% | 435B | |
| 0.00% | +0.83% | +42.80% | +37.60% | 361B | |
| +0.58% | -3.51% | +31.12% | +40.54% | 293B | |
| -1.55% | -9.78% | +5.61% | +8.62% | 251B | |
| -0.73% | +4.44% | +34.91% | +66.41% | 220B | |
| -0.24% | -13.15% | -4.02% | -44.69% | 201B | |
| -0.68% | -1.41% | +16.36% | +66.32% | 164B | |
| Average | +0.08% | -3.81% | +28.42% | +50.79% | 398.79B | |
| Weighted average by Cap. | +0.07% | -3.79% | +37.57% | +77.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.49B 5.17B 4.2B 3.84B 7.24B 492B 7.35B 49.16B 19.28B 246B 19.4B 18.98B 819B | 4.57B 5.27B 4.28B 3.92B 7.39B 501B 7.5B 50.13B 19.66B 251B 19.78B 19.35B 835B |
| Net income | 1.01B 1.17B 948M 868M 1.64B 111B 1.66B 11.1B 4.35B 55.64B 4.38B 4.29B 185B | 961M 1.11B 899M 823M 1.55B 105B 1.57B 10.53B 4.13B 52.77B 4.16B 4.06B 175B |
| Net Debt | -1.39B -1.6B -1.3B -1.19B -2.24B -152B -2.27B -15.2B -5.96B -76.17B -6B -5.87B -253B | -2.31B -2.66B -2.16B -1.98B -3.73B -253B -3.78B -25.31B -9.93B -127B -9.99B -9.77B -422B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | €161.40 | +1.51% | 624 |
| 26-08-05 | €159.00 | +1.27% | 36,155 |
| 26-08-04 | €157.00 | +2.55% | 1,209 |
| 26-08-03 | €153.10 | -8.43% | 452 |
| 26-07-31 | €167.20 | +5.89% | 1,062 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
- 0MH6 Stock
Select your edition
All financial news and data tailored to specific country editions
